SCHEMBL7929993

SCHEMBL7929993

COC(=O)c1ccc(-c2ccc3cc(C(=O)OCc4ccccc4)c(C45CC6CC(CC(C6)C4)C5)cc3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
THRB P10828 1/20 0.51
RECQL P46063 1/20 0.51
NR2E1 Q9Y466 1/20 0.51
RARB P10826 8/20 0.48
RARG P13631 8/20 0.48
RARA P10276 5/20 0.48
LMNA P02545 2/20 0.48
NR1I2 O75469 1/20 0.48
PGR P06401 1/20 0.48
HSPD1 P10809 1/20 0.48
GOT1 P17174 1/20 0.48
GLRA1 P23415 1/20 0.48
BLM P54132 1/20 0.48
HSPE1 P61604 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511260 0.92 MEN1 (0.61) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8766169 0.90 RARB (0.54) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7926514 0.86 RARB (0.54) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8439716 0.83 MEN1 (0.69) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8459789 0.83 MEN1 (0.45) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8766427 0.83 RARG (0.61) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8459793 0.83 KMT2A (0.45) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8662795 0.81 MEN1 (0.46) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8324536 0.81 MEN1 (0.56) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8765846 0.81 RARB (0.50) MEN1KMT2ATHRBRECQLNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP claimed
US-5723499-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof C.I.R.D. GALDERMA (FR) 1998-03-03 US claimed
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed
US-5723499-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof C.I.R.D. GALDERMA (FR) 1998-03-03 US disclosed